Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Limited-sampling models for anticancer agents

L J van Warmerdam¹, W W ten Bokkel Huinink, R A Maes

¹Department of Pharmacy, Slotervaart Hospital, Amsterdam, The Netherlands.

Journal of Cancer Research and Clinical Oncology

|January 1, 1994

Summary

Limited-sampling models (LSMs) reduce blood draws for antineoplastic drug pharmacokinetic analysis. These models aid in personalized dosing strategies by enabling population studies with fewer samples.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Propofol extravasation in a breast cancer patient.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2008

Same author

Complexation study of the anticancer agent EO-9 with 2-hydroxypropyl-beta-cyclodextrin.

Drug development and industrial pharmacy·2008

Same author

GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2008

Same author

Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.

British journal of cancer·2008

Same author

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography-triple quadrupole mass spectrometry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2008

Same author

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours.

British journal of cancer·2008

Area of Science:

Pharmacology
Clinical Pharmacy
Pharmacometrics

Background:

Traditional pharmacokinetic analysis of antineoplastic drugs requires frequent venipunctures.
This intensive sampling can be burdensome for patients and resource-intensive for studies.

Purpose of the Study:

To review the development, validation, and application of limited-sampling models (LSMs).
To highlight the potential of LSMs in facilitating population pharmacokinetic/pharmacodynamic studies.
To underscore the role of LSMs in advancing individualized patient dosing strategies.

Main Methods:

Review of literature on limited-sampling models (LSMs).
Analysis of methods for developing and validating LSMs.
Examination of LSM applications in pharmacokinetic and pharmacodynamic studies.

Related Experiment Videos

Main Results:

LSMs significantly reduce the number of required plasma samples (1-3) for pharmacokinetic profiling.
Validated LSMs provide reliable estimates of pharmacokinetic parameters.
LSMs are effective tools for population pharmacokinetic/pharmacodynamic analyses.

Conclusions:

Limited-sampling models offer a practical and efficient alternative to traditional intensive sampling for antineoplastic drug pharmacokinetics.
LSMs support the development of personalized medicine approaches through improved population studies.
Further research and application of LSMs can optimize cancer treatment regimens.